tocilizumab-anoh

Generic: tocilizumab

Labeler: celltrion usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name tocilizumab-anoh
Generic Name tocilizumab
Labeler celltrion usa, inc.
Dosage Form INJECTION, SOLUTION, CONCENTRATE
Routes
INTRAVENOUS
Active Ingredients

tocilizumab 200 mg/10mL

Manufacturer
CELLTRION USA, Inc.

Identifiers & Regulatory

Product NDC 72606-049
Product ID 72606-049_bacf86b8-9d2f-45d2-9c35-4f619ea494aa
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761420
Listing Expiration 2027-12-31
Marketing Start 2025-01-26

Pharmacologic Class

Established (EPC)
interleukin-6 receptor antagonist [epc]
Mechanism of Action
interleukin 6 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72606049
Hyphenated Format 72606-049

Supplemental Identifiers

RxCUI
2705425 2705435 2705443 2705450 2705452
UNII
I031V2H011
NUI
N0000190478 N0000190480

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tocilizumab-anoh (source: ndc)
Generic Name tocilizumab (source: ndc)
Application Number BLA761420 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 200 mg/10mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (72606-049-01) / 10 mL in 1 VIAL, SINGLE-DOSE
  • 4 VIAL, SINGLE-DOSE in 1 CARTON (72606-049-02) / 10 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (2)

72606-049-01 1 VIAL, SINGLE-DOSE in 1 CARTON (72606-049-01) / 10 mL in 1 VIAL, SINGLE-DOSE 72606-049-02 4 VIAL, SINGLE-DOSE in 1 CARTON (72606-049-02) / 10 mL in 1 VIAL, SINGLE-DOSE

Ingredients (1)

tocilizumab (200 mg/10mL)

Linked Drug Pages (1)

Tocilizumab-anoh ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "bacf86b8-9d2f-45d2-9c35-4f619ea494aa", "openfda": {"nui": ["N0000190478", "N0000190480"], "unii": ["I031V2H011"], "rxcui": ["2705425", "2705435", "2705443", "2705450", "2705452"], "spl_set_id": ["60381a7e-d7ae-4384-925d-c19c418d1663"], "pharm_class_epc": ["Interleukin-6 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Interleukin 6 Receptor Antagonists [MoA]"], "manufacturer_name": ["CELLTRION USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (72606-049-01)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "72606-049-01", "marketing_start_date": "20250126"}, {"sample": false, "description": "4 VIAL, SINGLE-DOSE in 1 CARTON (72606-049-02)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "72606-049-02", "marketing_start_date": "20250126"}], "brand_name": "Tocilizumab-anoh", "product_id": "72606-049_bacf86b8-9d2f-45d2-9c35-4f619ea494aa", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["Interleukin 6 Receptor Antagonists [MoA]", "Interleukin-6 Receptor Antagonist [EPC]"], "product_ndc": "72606-049", "generic_name": "tocilizumab", "labeler_name": "CELLTRION USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tocilizumab-anoh", "active_ingredients": [{"name": "TOCILIZUMAB", "strength": "200 mg/10mL"}], "application_number": "BLA761420", "marketing_category": "BLA", "marketing_start_date": "20250126", "listing_expiration_date": "20271231"}